(Q52544307)

3 May 2018

title

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. (English)

1 reference

3 May 2018

author name string

Bayer-Garner IB

1 reference

3 May 2018

Sanderson RD

1 reference

3 May 2018

Dhodapkar MV

1 reference

3 May 2018

Owens RB

1 reference

3 May 2018

Wilson CS

1 reference

3 May 2018

publication date

1 October 2001

1 reference

3 May 2018

published in

Modern Pathology

1 reference

3 May 2018

volume

1 reference

3 May 2018

issue

1 reference

3 May 2018

page(s)

1052-1058

1 reference

3 May 2018

Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Detection of myeloma cells in the peripheral blood by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Quantitation of Bone Marrow Reticulin—A Normal Range

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Identification and location on syndecan-1 core protein of the epitopes of B-B2 and B-B4 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Cytoplasmic immunoglobulin content in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

The ins and outs of fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880435

7 January 2021

10.1038/MODPATHOL.3880435

Identifiers

DOI

1 reference

3 May 2018

1 reference

3 May 2018